Free Trial

Medtronic (MDT) 10K Form and Latest SEC Filings 2026

Medtronic logo
$101.64 +0.05 (+0.04%)
Closing price 03:59 PM Eastern
Extended Trading
$101.37 -0.26 (-0.26%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Medtronic SEC Filings & Recent Activity

Medtronic (NYSE:MDT) has submitted 706+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Medtronic's financial statements. The most recent filing was a Form SCHEDULE 13G submitted on November 10, 2026.

Form 4
Medtronic plc Reports Ownership Change on Nov. 4, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Medtronic Files Current Report on Oct. 19, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Medtronic Files Quarterly Report on Sep. 3, 2026

The 10-Q contains Medtronic's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Medtronic SEC Filing History

Browse Medtronic's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

Filing Date
0 Results
DateFilerForm TypeView
11/10/2026 7:41 AM
Medtronic (1613103) Subject
STATE STREET CORP (93751) Filed by
STATE STREET CORP (93751) Filed by
Form SCHEDULE 13G
11/04/2026 3:37 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2026 4:18 PM
Lofton Kevin E (1468818) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2026 3:12 PM
Medtronic (1613103) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
10/21/2026 3:13 PM
Medtronic (1613103) Filer
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
10/19/2026 3:23 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2026 5:00 PM
Martha Geoffrey (1560409) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2026 5:02 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2026 3:18 PM
Medtronic (1613103) Reporting
MiniMed Group, Inc. (2062583) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2026 3:21 PM
Medtronic (1613103) Filed by
MiniMed Group, Inc. (2062583) Subject
Form SCHEDULE 13G/A
10/15/2026 4:00 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2026 8:41 AM
Martha Geoffrey (1560409) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/14/2026 7:20 AM
Medtronic (1613103) Subject
Form SC TO-I/A
10/14/2026 7:05 AM
Medtronic (1613103) Subject
Form 425
10/13/2026 7:18 AM
Medtronic (1613103) Subject
Form SC TO-I/A
10/13/2026 7:02 AM
Medtronic (1613103) Subject
Form 425
10/09/2026 3:48 PM
Medtronic (1613103) Subject
Form 425
10/08/2026 3:42 PM
Medtronic (1613103) Subject
Form 425
10/08/2026 7:24 AM
Medtronic (1613103) Subject
Form SC TO-I/A
10/08/2026 7:04 AM
Medtronic (1613103) Subject
Form 425
10/07/2026 4:02 PM
Medtronic (1613103) Subject
Form 425
10/06/2026 3:43 PM
Medtronic (1613103) Subject
Form 425
10/02/2026 4:07 PM
Medtronic (1613103) Subject
Form 425
10/01/2026 3:57 PM
Medtronic (1613103) Subject
Form 425
09/30/2026 3:47 PM
Medtronic (1613103) Subject
Form 425
09/29/2026 3:41 PM
Medtronic (1613103) Subject
Form 425
09/28/2026 3:51 PM
Medtronic (1613103) Subject
Form 425
09/25/2026 3:43 PM
Medtronic (1613103) Subject
Form 425
09/24/2026 3:49 PM
Medtronic (1613103) Subject
Form 425
09/23/2026 3:52 PM
Medtronic (1613103) Subject
Form 425
09/22/2026 3:52 PM
Medtronic (1613103) Subject
Form 425
09/21/2026 4:04 PM
Medtronic (1613103) Subject
Form 425
09/21/2026 3:10 PM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/18/2026 3:41 PM
Medtronic (1613103) Subject
Form 425
09/17/2026 3:44 PM
Medtronic (1613103) Subject
Form 425
09/17/2026 3:17 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2026 3:19 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2026 3:19 PM
Medtronic (1613103) Subject
Form 425
09/17/2026 3:20 PM
Medtronic (1613103) Subject
Form SC TO-I/A
09/16/2026 4:25 PM
Medtronic (1613103) Subject
Form 425
09/16/2026 4:25 PM
Medtronic (1613103) Subject
Form 425
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
09/16/2026 3:16 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2026 1:37 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2026 4:08 PM
Medtronic (1613103) Subject
Form 425
09/14/2026 4:22 PM
Medtronic (1613103) Subject
Form 425
09/14/2026 3:33 PM
Medtronic (1613103) Subject
Form 425
09/14/2026 3:33 PM
Medtronic (1613103) Subject
Form 425
09/14/2026 8:23 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 7:58 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 8:01 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 8:03 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 8:05 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 7:51 AM
Medtronic (1613103) Subject
Form 425
09/14/2026 7:51 AM
Medtronic (1613103) Subject
Form 425
09/14/2026 7:51 AM
Medtronic (1613103) Subject
Form 425
09/14/2026 7:52 AM
Medtronic (1613103) Subject
Form 425
09/14/2026 7:00 AM
Medtronic (1613103) Subject
Form SC TO-I
09/14/2026 6:40 AM
Medtronic (1613103) Subject
MiniMed Group, Inc. (2062583) Filed by
Form 425
09/14/2026 6:40 AM
Medtronic (1613103) Subject
Form 425
09/03/2026 3:18 PM
Medtronic (1613103) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/01/2026 5:47 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2026 4:04 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2026 3:33 PM
Medtronic (1613103) Filer
Form DEF 14A
08/17/2026 3:34 PM
Medtronic (1613103) Filer
Form DEFA14A
08/04/2026 6:57 PM
Martha Geoffrey (1560409) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 6:58 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 6:58 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 6:59 PM
Medtronic (1613103) Issuer
Pieton Thierry (2056622) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 6:59 PM
Medtronic (1613103) Issuer
Quinn Michelle (1964281) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 6:59 PM
Medtronic (1613103) Issuer
Thompson Kweli (2137804) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 7:00 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2026 7:00 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2026 3:26 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 9:15 AM
Medtronic (1613103) Subject
Walter Matthew R. (2028475) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2026 3:28 PM
Medtronic (1613103) Filer
Form IRANNOTICE
06/09/2026 3:16 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 4:07 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 4:01 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 4:02 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 4:02 PM
Marinaro Michael (1984186) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 4:03 PM
Martha Geoffrey (1560409) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2026 1:34 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2026 5:47 AM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2026 3:30 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 7:11 PM
Medtronic (1613103) Filed by
MiniMed Group, Inc. (2062583) Subject
Form SCHEDULE 13G
05/04/2026 4:12 PM
Medtronic (1613103) Issuer
Walter Matthew R. (2028475) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:15 PM
Jellison William R (1189883) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:15 PM
Lee Joon Sup (2075730) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:16 PM
Lewis Gregory P (1748656) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:16 PM
Lofton Kevin E (1468818) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:17 PM
Medtronic (1613103) Issuer
NABEL ELIZABETH G (1619929) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
I'm handing you this one free (Ad)

Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel

See today's free stock pick before the December 8th deadline here
04/29/2026 3:18 PM
Medtronic (1613103) Issuer
Powell Kendall J (1298823) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2026 3:18 PM
Blomquist Denise L. (2061393) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2026 11:26 AM
Medtronic (1613103) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
03/27/2026 9:30 AM
Medtronic (1613103) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/24/2026 3:42 PM
Medtronic (1613103) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2026 3:15 PM
Medtronic Global Holdings S.C.A. (1647572) Filer
MEDTRONIC INC (64670) Filer
Medtronic (1613103) Filer
Form S-3ASR
03/05/2026 7:39 PM
Medtronic (1613103) Reporting
MiniMed Group, Inc. (2062583) Issuer
Form 3
Initial statement of beneficial ownership of securities  
03/05/2026 4:22 PM
Medtronic (1613103) Issuer
Pieton Thierry (2056622) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2026 4:48 PM
KIIL HARRY SKIP (1708062) Reporting
Medtronic (1613103) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Medtronic SEC Filings - Frequently Asked Questions

Medtronic (MDT) has submitted 706+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Medtronic's fiscal year ends on April 30. The company typically files its 10-K annual report by the end of June, covering the prior fiscal year's financial results. Key financial data from these reports is available on Medtronic's financial statements page.

The most recent filing was a Form SCHEDULE 13G submitted on November 10, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NYSE:MDT are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 11/10/2026. New filings are added as they're published.
From Our Partners